Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;